Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hemostemix Inc. stock logo
HEM
Hemostemix
C$0.05
+12.5%
C$0.07
C$0.04
C$0.18
C$4.04M0.5545,488 shs32,000 shs
Medicure Inc. stock logo
MPH
Medicure
C$1.00
-2.0%
C$1.13
C$0.99
C$1.80
C$10.25M1.014,487 shs4,900 shs
Newfield Exploration stock logo
NFX
Newfield Exploration
$17.07
$0.00
$12.45
$31.46
$3.43B1.858.80 million shsN/A
Insperity, Inc. stock logo
NSP
Insperity
$104.17
-4.4%
$103.13
$90.80
$128.91
$3.92B1.14330,053 shs415,094 shs
Valaris Limited stock logo
VAL
Valaris
$69.23
+2.1%
$69.58
$54.13
$78.92
$5.01B1.13868,482 shs464,242 shs
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hemostemix Inc. stock logo
HEM
Hemostemix
-11.11%-20.00%-38.46%-46.67%-75.00%
Medicure Inc. stock logo
MPH
Medicure
-6.42%-0.97%-15.00%-12.07%-22.14%
Newfield Exploration stock logo
NFX
Newfield Exploration
0.00%0.00%0.00%0.00%0.00%
Insperity, Inc. stock logo
NSP
Insperity
-0.55%+1.99%+3.11%-4.92%-9.06%
Valaris Limited stock logo
VAL
Valaris
+0.41%+1.04%-5.86%-1.41%+15.47%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Hemostemix Inc. stock logo
HEM
Hemostemix
N/AN/AN/AN/AN/AN/AN/AN/A
Medicure Inc. stock logo
MPH
Medicure
N/AN/AN/AN/AN/AN/AN/AN/A
Newfield Exploration stock logo
NFX
Newfield Exploration
N/AN/AN/AN/AN/AN/AN/AN/A
Insperity, Inc. stock logo
NSP
Insperity
4.7575 of 5 stars
2.04.03.33.53.11.73.1
Valaris Limited stock logo
VAL
Valaris
3.3304 of 5 stars
3.51.00.00.02.51.73.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Hemostemix Inc. stock logo
HEM
Hemostemix
N/AN/AN/AN/A
Medicure Inc. stock logo
MPH
Medicure
N/AN/AN/AN/A
Newfield Exploration stock logo
NFX
Newfield Exploration
N/AN/AN/AN/A
Insperity, Inc. stock logo
NSP
Insperity
2.00
Hold$115.0010.40% Upside
Valaris Limited stock logo
VAL
Valaris
3.00
Buy$100.0044.45% Upside

Current Analyst Ratings

Latest NSP, MPH, VAL, HEM, and NFX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/5/2024
Valaris Limited stock logo
VAL
Valaris
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$105.00 ➝ $102.00
2/23/2024
Valaris Limited stock logo
VAL
Valaris
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$107.00 ➝ $105.00
2/14/2024
Valaris Limited stock logo
VAL
Valaris
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$106.00 ➝ $105.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Hemostemix Inc. stock logo
HEM
Hemostemix
N/AN/AC$0.00 per share10.77C($0.08) per shareN/A
Medicure Inc. stock logo
MPH
Medicure
C$22.94M0.45C$0.40 per share2.49C$2.10 per share0.48
Newfield Exploration stock logo
NFX
Newfield Exploration
$1.77B1.94$4.50 per share3.79$7.05 per share2.42
Insperity, Inc. stock logo
NSP
Insperity
$6.49B0.60$5.14 per share20.27$2.51 per share41.50
Valaris Limited stock logo
VAL
Valaris
$1.78B2.81$2.59 per share26.72$27.40 per share2.53

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Hemostemix Inc. stock logo
HEM
Hemostemix
-C$3.17M-C$0.04N/AN/AN/AN/A-165.67%N/A
Medicure Inc. stock logo
MPH
Medicure
C$1.08MC$0.0911.11N/A4.71%5.04%2.49%5/24/2024 (Estimated)
Newfield Exploration stock logo
NFX
Newfield Exploration
$427M$2.157.945.170.3721.14%43.65%13.21%N/A
Insperity, Inc. stock logo
NSP
Insperity
$171.38M$4.4623.3636.943.132.64%153.34%8.42%5/1/2024 (Confirmed)
Valaris Limited stock logo
VAL
Valaris
$865.40M$11.695.926.67N/A48.50%5.71%2.40%5/2/2024 (Confirmed)

Latest NSP, MPH, VAL, HEM, and NFX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024N/A
Valaris Limited stock logo
VAL
Valaris
$0.40N/A-$0.40N/AN/AN/A  
5/1/2024N/A
Insperity, Inc. stock logo
NSP
Insperity
$1.84N/A-$1.84N/AN/AN/A  
4/8/2024Q4 2023
Medicure Inc. stock logo
MPH
Medicure
N/A-C$0.14-C$0.14-C$0.14N/AC$5.07 million
2/21/2024Q4 2023
Valaris Limited stock logo
VAL
Valaris
$0.29$0.61+$0.32-$10.08$484.00 million$483.80 million
2/8/2024Q4 2023
Insperity, Inc. stock logo
NSP
Insperity
$0.38$0.46+$0.08$0.40$1.57 billion$1.58 billion

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Hemostemix Inc. stock logo
HEM
Hemostemix
N/AN/AN/AN/AN/A
Medicure Inc. stock logo
MPH
Medicure
N/AN/AN/AN/AN/A
Newfield Exploration stock logo
NFX
Newfield Exploration
N/AN/AN/AN/AN/A
Insperity, Inc. stock logo
NSP
Insperity
$2.282.19%+11.70%51.12%13 Years
Valaris Limited stock logo
VAL
Valaris
N/AN/AN/AN/AN/A

Latest NSP, MPH, VAL, HEM, and NFX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/22/2024
Insperity, Inc. stock logo
NSP
Insperity
Quarterly$0.572.34%3/6/20243/7/20243/21/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Hemostemix Inc. stock logo
HEM
Hemostemix
N/A
0.25
0.48
Medicure Inc. stock logo
MPH
Medicure
2.86
2.28
1.29
Newfield Exploration stock logo
NFX
Newfield Exploration
1.30
0.72
0.70
Insperity, Inc. stock logo
NSP
Insperity
3.95
1.11
1.11
Valaris Limited stock logo
VAL
Valaris
0.54
1.71
1.71

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Hemostemix Inc. stock logo
HEM
Hemostemix
N/A
Medicure Inc. stock logo
MPH
Medicure
23.10%
Newfield Exploration stock logo
NFX
Newfield Exploration
97.87%
Insperity, Inc. stock logo
NSP
Insperity
93.44%
Valaris Limited stock logo
VAL
Valaris
96.74%

Insider Ownership

CompanyInsider Ownership
Hemostemix Inc. stock logo
HEM
Hemostemix
12.15%
Medicure Inc. stock logo
MPH
Medicure
26.99%
Newfield Exploration stock logo
NFX
Newfield Exploration
0.59%
Insperity, Inc. stock logo
NSP
Insperity
5.50%
Valaris Limited stock logo
VAL
Valaris
0.11%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Hemostemix Inc. stock logo
HEM
Hemostemix
N/A89.79 millionN/ANot Optionable
Medicure Inc. stock logo
MPH
Medicure
N/A10.25 millionN/ANot Optionable
Newfield Exploration stock logo
NFX
Newfield Exploration
N/A200.93 millionN/AOptionable
Insperity, Inc. stock logo
NSP
Insperity
4,40037.65 million35.58 millionOptionable
Valaris Limited stock logo
VAL
Valaris
5,98572.41 million72.33 millionOptionable

NSP, MPH, VAL, HEM, and NFX Headlines

SourceHeadline
Valaris Limited (NYSE:VAL) Given Consensus Recommendation of "Buy" by AnalystsValaris Limited (NYSE:VAL) Given Consensus Recommendation of "Buy" by Analysts
americanbankingnews.com - April 26 at 3:08 AM
Valaris (NYSE:VAL) Upgraded by StockNews.com to "Sell"Valaris (NYSE:VAL) Upgraded by StockNews.com to "Sell"
americanbankingnews.com - April 26 at 2:18 AM
Equinor rolls up its sleeves for imminent Argentina exploration wellEquinor rolls up its sleeves for imminent Argentina exploration well
upstreamonline.com - April 25 at 9:14 AM
Valaris (VAL) Set to Announce Quarterly Earnings on ThursdayValaris (VAL) Set to Announce Quarterly Earnings on Thursday
americanbankingnews.com - April 25 at 2:32 AM
Louisiana State Employees Retirement System Takes $1.21 Million Position in Valaris Limited (NYSE:VAL)Louisiana State Employees Retirement System Takes $1.21 Million Position in Valaris Limited (NYSE:VAL)
marketbeat.com - April 23 at 4:51 AM
John Fredriksen ally wins seat on board of potential takeover target International SeawaysJohn Fredriksen ally wins seat on board of potential takeover target International Seaways
tradewindsnews.com - April 18 at 10:48 PM
Valaris Limited (NYSE:VAL) Shares Sold by River Road Asset Management LLCValaris Limited (NYSE:VAL) Shares Sold by River Road Asset Management LLC
marketbeat.com - April 18 at 9:34 AM
Interocean announces UT technology demonstrationInterocean announces UT technology demonstration
zawya.com - April 16 at 8:33 AM
Mutual of America Capital Management LLC Acquires 38,367 Shares of Valaris Limited (NYSE:VAL)Mutual of America Capital Management LLC Acquires 38,367 Shares of Valaris Limited (NYSE:VAL)
marketbeat.com - April 14 at 6:11 AM
Valaris Schedules First Quarter 2024 Earnings Release and Conference CallValaris Schedules First Quarter 2024 Earnings Release and Conference Call
businesswire.com - April 11 at 4:30 PM
Aramco Suspends Valaris Rig ContractAramco Suspends Valaris Rig Contract
rigzone.com - April 11 at 1:38 AM
Valaris (VAL) Receives Rigs Suspension Notice From AramcoValaris (VAL) Receives Rig's Suspension Notice From Aramco
zacks.com - April 9 at 2:26 PM
Lancaster Investment Management Buys Shares of 400,116 Valaris Limited (NYSE:VAL)Lancaster Investment Management Buys Shares of 400,116 Valaris Limited (NYSE:VAL)
marketbeat.com - April 9 at 12:12 PM
Port Everglades marks commissioning of new container cranesPort Everglades marks commissioning of new container cranes
en.portnews.ru - April 7 at 11:30 AM
Valaris faces rig suspension in Saudi joint ventureValaris faces rig suspension in Saudi joint venture
investing.com - April 6 at 2:41 AM
Aramco Suspends Another Jack-Up RigAramco Suspends Another Jack-Up Rig
oedigital.com - April 5 at 4:40 PM
Suspension notice for Valaris joint ventureSuspension notice for Valaris joint venture
royalgazette.com - April 5 at 4:40 PM
Saudi Aramco suspends offshore rig deal with New York-listed playerSaudi Aramco suspends offshore rig deal with New York-listed player
upstreamonline.com - April 5 at 1:44 AM
Aramco suspends jackup contract with offshore drillerAramco suspends jackup contract with offshore driller
upstreamonline.com - April 4 at 8:43 PM
Valaris (NYSE:VAL) Shares Gap Down to $76.66Valaris (NYSE:VAL) Shares Gap Down to $76.66
marketbeat.com - April 4 at 2:02 PM
Valaris Limited (NYSE:VAL) Shares Purchased by Vanguard Group Inc.Valaris Limited (NYSE:VAL) Shares Purchased by Vanguard Group Inc.
marketbeat.com - April 3 at 4:09 AM
Valaris: Buy Despite Near-Term Jackup Market HeadwindsValaris: Buy Despite Near-Term Jackup Market Headwinds
seekingalpha.com - April 2 at 7:31 PM
VAL Quantitative Stock AnalysisVAL Quantitative Stock Analysis
nasdaq.com - April 1 at 6:26 PM
Valaris Limited (NYSE:VAL) Receives Consensus Recommendation of "Buy" from AnalystsValaris Limited (NYSE:VAL) Receives Consensus Recommendation of "Buy" from Analysts
marketbeat.com - April 1 at 4:14 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Hemostemix logo

Hemostemix

CVE:HEM
Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions. The company develops cell therapy products from the patient's own blood, which is a non-invasive source of therapeutic cells. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of vascular diseases, such as cardiovascular disease, peripheral arterial disease, angina pectoris, and ischemia in Canada and the United States. The company is also developing various types of cell products, such as synergetic cell populations, neural cell precursors, and cardiomyocyte cell precursors. Hemostemix Inc. is headquartered in Calgary, Canada.
Medicure logo

Medicure

CVE:MPH
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company offers Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.
Newfield Exploration logo

Newfield Exploration

NYSE:NFX
Newfield Exploration Company, an independent energy company, engages in the exploration, development, and production of crude oil, natural gas, and natural gas liquids in the United States. The company has operations principally in the Anadarko and Arkoma basins of Oklahoma, the Williston Basin of North Dakota, and the Uinta Basin of Utah. It also holds oil producing assets offshore China. The company was founded in 1988 and is headquartered in The Woodlands, Texas.
Insperity logo

Insperity

NYSE:NSP
Insperity, Inc. engages in the provision of human resources (HR) and business solutions to improve business performance for small and medium-sized businesses primarily in the United States. It offers its HR services through its workforce optimization and workforce synchronization solutions that include a range of human resources functions, such as payroll and employment administration, employee benefits, workers' compensation, government compliance, performance management, and training and development services. The company also provides Insperity Premier, a cloud-based human capital management platform that offers professional employer organization HR outsourcing solutions to its clients; people management services; and employer liability management services, as well as solutions for middle market. In addition, it offers MarketPlace, an e-commerce portal that offers a range of products and services; and Workforce Acceleration, a human capital management and payroll services solution; integrated payroll; benefits administration; HR administration and employee onboarding; time and attendance; performance management; reporting and analytics; recruiting; employment screening; retirement; and insurance services. The company was formerly known as Administaff, Inc. and changed its name to Insperity, Inc. in March 2011. Insperity, Inc. was founded in 1986 and is headquartered in Kingwood, Texas.
Valaris logo

Valaris

NYSE:VAL
Valaris Limited, together with its subsidiaries, provides offshore contract drilling services Gulf of Mexico, South America, North Sea, the Middle East, Africa, and the Asia Pacific. The company operates through four segments: Floaters, Jackups, ARO, and Other. It owns an offshore drilling rig fleet, which include drillships, dynamically positioned semisubmersible rigs, moored semisubmersible rig, and jackup rigs. It serves international, government-owned, and independent oil and gas. Valaris Limited was founded in 1975 and is based in Hamilton, Bermuda.